T1	PROC 46 78	Ensayo clínico sobre la eficacia
T2	CHEM 82 93	tocilizumab
#1	AnnotatorNotes T2	C1609165; tocilizumab; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T3	DISO 131 144	inflamatorios
#2	AnnotatorNotes T3	C0021368; Inflammation; Pathologic Function
T4	PROC 193 262	Ensayo clínico unicéntrico, aleatorizado y abierto, sobre la eficacia
T5	CHEM 266 277	tocilizumab
#3	AnnotatorNotes T5	C1609165; tocilizumab; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T6	DISO 315 328	inflamatorios
#4	AnnotatorNotes T6	C0021368; Inflammation; Pathologic Function
T7	DISO 378 399	Neumonía por COVID-19
T8	DISO 426 456	Neumonía no grave por COVID-19
T9	PROC 706 719	diagnosticado
#5	AnnotatorNotes T9	C0011900; Diagnosis; Diagnostic Procedure
T10	DISO 723 760	neumonía leve-moderada por SARS-CoV-2
T11	PROC 923 932	PaO2/FiO2
#6	AnnotatorNotes T11	C3897988; Partial Pressure Arterial Oxygen to Fraction Inspired Oxygen Ratio Measurement; Laboratory Procedure
T12	PROC 843 870	Saturación basal de oxígeno
T13	PROC 812 826	aleatorización
#7	AnnotatorNotes T13	C0034656; Randomization; Research Activity
T14	CHEM 863 870	oxígeno
#8	AnnotatorNotes T14	C0030054; oxygen; Biologically Active Substance · Element, Ion, or Isotope · Pharmacologic Substance
T15	CHEM 891 895	IL-6
#9	AnnotatorNotes T15	C0021760; interleukin-6; Amino Acid, Peptide, or Protein · Immunologic Factor | C1698754; IL6 protein, human; Amino Acid, Peptide, or Protein · Biologically Active Substance | C2983957; interleukin-6, human; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T16	PROC 880 895	Niveles de IL-6
T17	PROC 986 999	hospitalizado
#10	AnnotatorNotes T17	C0019993; Hospitalization; Health Care Activity
T18	PROC 1022 1042	ingreso hospitalario
#11	AnnotatorNotes T18	C0184666; Hospital admission; Health Care Activity
T19	PROC 1174 1188	ensayo clínico
#12	AnnotatorNotes T19	C0008976; Clinical Trials; Research Activity
T20	DISO 1239 1281	Coinfección por el virus de la hepatitis B
T21	PROC 1076 1088	entre en UCI
T22	DISO 1434 1446	alteraciones
#13	AnnotatorNotes T22	C0221423; Illness (finding); Sign or Symptom
T23	PROC 558 582	consentimiento informado
#14	AnnotatorNotes T23	C0567423; Informed consent for procedure; Therapeutic or Preventive Procedure
T24	DISO 1091 1099	fallezca
#15	AnnotatorNotes T24	C1306577; Death (finding); Finding | C1546956; Patient Outcome - Died; Finding
T25	CHEM 1217 1234	inmunomoduladores
#16	AnnotatorNotes T25	C1527392; Immunomodulators; Immunologic Factor · Pharmacologic Substance
T26	CHEM 1283 1292	AgSup-VHB
T27	PROC 941 946	SatO2
#17	AnnotatorNotes T27	C0523807; Oxygen saturation measurement; Laboratory Procedure
T28	PROC 947 951	FiO2
#18	AnnotatorNotes T28	C1512797; Inspired Oxygen Fraction Test; Diagnostic Procedure
T29	DISO 162 170	COVID-19
#19	AnnotatorNotes T29	C5203670; COVID19 (disease); Disease or Syndrome
T30	DISO 346 354	COVID-19
#20	AnnotatorNotes T30	C5203670; COVID19 (disease); Disease or Syndrome
T31	Date 13 17	2020
T32	LIVB 148 157	pacientes
#21	AnnotatorNotes T32	C0030705; Patients; Patient or Disabled Group
T33	LIVB 332 341	pacientes
#22	AnnotatorNotes T33	C0030705; Patients; Patient or Disabled Group
T35	LIVB 486 495	Pacientes
#23	AnnotatorNotes T35	C0030705; Patients; Patient or Disabled Group
T36	Age 496 535	mayores de 18 años y menores de 80 años
T37	LIVB 664 683	médico investigador
#24	AnnotatorNotes T37	C0687734; Medical researcher; Professional or Occupational Group
T38	LIVB 692 700	paciente
#25	AnnotatorNotes T38	C0030705; Patients; Patient or Disabled Group
T39	LIVB 750 760	SARS-CoV-2
#26	AnnotatorNotes T39	C5203676; SARS-CoV-2; Virus
T40	Duration 792 799	≤7 días
T41	LIVB 964 972	paciente
#27	AnnotatorNotes T41	C0030705; Patients; Patient or Disabled Group
T42	LIVB 1050 1058	paciente
#28	AnnotatorNotes T42	C0030705; Patients; Patient or Disabled Group
T43	Neg_cue 1059 1061	no
T44	Duration 1103 1121	las siguientes 24h
T46	LIVB 1258 1281	virus de la hepatitis B
#29	AnnotatorNotes T46	C0019169; hepatitis B virus; Virus
T47	LIVB 1289 1292	VHB
#30	AnnotatorNotes T47	C0019169; hepatitis B virus; Virus
T49	PHYS 1347 1357	embarazada
#31	AnnotatorNotes T49	C0032961; Pregnancy; Organism Function
T45	PHYS 1309 1317	Embarazo
#32	AnnotatorNotes T45	C0032961; Pregnancy; Organism Function
T48	PHYS 1407 1416	lactancia
#33	AnnotatorNotes T48	C0006147; Breast Feeding; Organism Function | C0022925; Lactation; Organ or Tissue Function
T34	LIVB 1152 1165	Participantes
#34	AnnotatorNotes T34	C4554048; Study Participant; Population Group
T50	PROC 772 791	microbiológicamente
A1	Assertion T21 Negated
A2	Assertion T24 Negated
#35	AnnotatorNotes T1	C1707887; Efficacy Study; Research Activity 
#36	AnnotatorNotes T7	C5419163; COVID-19-Associated Pneumonia; Disease or Syndrome 
#37	AnnotatorNotes T16	C0919829; Interleukin 6 Measurement; Laboratory Procedure
#38	AnnotatorNotes T21	C0583239; Admission to intensive care unit; Health Care Activity
T51	Quantifier_or_Qualifier 438 443	grave
A3	Assertion T51 Negated
#39	AnnotatorNotes T51	C1547227; Severe - Severity of Illness Code; Intellectual Product
T52	Neg_cue 435 437	no
T53	CONC 120 144	parámetros inflamatorios
T54	CONC 304 328	parámetros inflamatorios
R1	Experiences Arg1:T32 Arg2:T2	
R2	Experiences Arg1:T32 Arg2:T3	
R3	Experiences Arg1:T32 Arg2:T29	
R4	Experiences Arg1:T33 Arg2:T5	
R5	Experiences Arg1:T33 Arg2:T6	
R6	Experiences Arg1:T33 Arg2:T30	
R7	Causes Arg1:T29 Arg2:T3	
R8	Causes Arg1:T30 Arg2:T6	
R9	Negation Arg1:T52 Arg2:T51	
R10	Has_Quantifier_or_Qualifier Arg1:T8 Arg2:T51	
R11	Has_Age Arg1:T35 Arg2:T36	
T57	CONC 640 656	historia clínica
#42	AnnotatorNotes T57	C5204342; Clinical History; Intellectual Product
R12	Experiences Arg1:T38 Arg2:T10	
R13	Causes Arg1:T39 Arg2:T10	
R15	Overlap Arg1:T50 Arg2:T40	
R16	Before Arg1:T50 Arg2:T13	
#43	AnnotatorNotes T50	C0085672; Microbiology procedure; Laboratory Procedure
T58	Result_or_Value 871 875	>90%
R17	Has_Result_or_Value Arg1:T12 Arg2:T58	
T59	Result_or_Value 896 905	>40 pg/ml
R18	Has_Result_or_Value Arg1:T16 Arg2:T59	
R19	Experiences Arg1:T38 Arg2:T50	
R20	Before Arg1:T50 Arg2:T9	
T60	CONC 909 916	CURB-65
#44	AnnotatorNotes T60	[CURB criteria for predicting mortality in community-acquired pneumonia] 
T61	Result_or_Value 917 919	≥1
R21	Has_Result_or_Value Arg1:T60 Arg2:T61	
T62	Result_or_Value 933 938	≤ 300
R22	Has_Result_or_Value Arg1:T11 Arg2:T62	
T63	Result_or_Value 952 957	≤ 315
R23	Has_Result_or_Value Arg1:T28 Arg2:T63	
R24	Has_Result_or_Value Arg1:T27 Arg2:T63	
R25	Experiences Arg1:T41 Arg2:T17	
R27	Negation Arg1:T43 Arg2:T21	
R28	Experiences Arg1:T42 Arg2:T21	
T64	Observation 1002 1042	cumple criterios de ingreso hospitalario
R29	Before Arg1:T64 Arg2:T18	
R30	Negation Arg1:T43 Arg2:T24	
R31	After Arg1:T24 Arg2:T44	
R32	Experiences Arg1:T42 Arg2:T24	
T65	Observation 1174 1199	ensayo clínico simultáneo
T66	Quantifier_or_Qualifier 1211 1216	otros
#45	AnnotatorNotes T66	C0205394; Other; Qualitative Concept
R34	Has_Quantifier_or_Qualifier Arg1:T25 Arg2:T66	
R35	Causes Arg1:T46 Arg2:T20	
T67	Observation 1293 1303	detectable
#46	AnnotatorNotes T67	C0442726; Detected (finding); Finding
R36	Has_Quantifier_or_Qualifier Arg1:T26 Arg2:T67	
R37	Causes Arg1:T47 Arg2:T67	
R38	Causes Arg1:T46 Arg2:T67	
R39	Overlap Arg1:T20 Arg2:T67	
T68	Observation 1321 1357	planificación de quedarse embarazada
#47	AnnotatorNotes T68	C0032992; Pregnancy, Planned; Finding
R40	Before Arg1:T68 Arg2:T49	
T69	PROC 1384 1391	estudio
#48	AnnotatorNotes T69	C0008976; Clinical Trials; Research Activity
R42	Overlap Arg1:T45 Arg2:T69	
R43	Overlap Arg1:T69 Arg2:T48	
R41	Overlap Arg1:T68 Arg2:T69	
T70	Quantifier_or_Qualifier 1465 1474	grado ≥ 4
T71	Observation 1434 1461	alteraciones de laboratorio
#49	AnnotatorNotes T71	C3648370; laboratory tests nonspecific abnormal findings; Finding
R44	Has_Quantifier_or_Qualifier Arg1:T71 Arg2:T70	
R14	Experiences Arg1:T41 Arg2:T18	
#40	AnnotatorNotes T26	C0019168; Hepatitis B Surface Antigens; Amino Acid, Peptide, or Protein · Pharmacologic Substance · Immunologic Factor
A4	Experiencer T42 Patient
A5	Experiencer T41 Patient
A6	Experiencer T34 Patient
A7	Status T49 Future
A8	Experiencer T32 Patient
A9	Experiencer T33 Patient
A10	Experiencer T35 Patient
A11	Experiencer T37 Other
A12	Experiencer T38 Patient
